Vol. 15 No. 4 (2022)

A Current View on Pathogenesis, Diagnosis, and Treatment of Some Rare Acute Leukemia Variants

Experimental Study of the In Vitro and In Vivo Functional Activity of NKG2D Chimeric Antigen Receptor

• PDF_2022-15-4-327-339 (Russian)

Production of CD87 Antigen-Specific CAR-T Lymphocytes and Assessment of Their In Vitro Functional Activity

• PDF_2022-15-4-340-348 (Russian)

Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

• PDF_2022-15-4-349-355 (Russian)

Plasmablastic Lymphoma with Primary Impairment of Bone Marrow in a HIV-Negative Patient: A Literature Review and a Case Report

• PDF_2022-15-4-356-364 (Russian)

Multiple Myeloma: Nuances of Minimal Residual Disease Diagnosis and Monitoring with the Use of Multicolor Flow Cytometry

• PDF_2022-15-4-365-376 (Russian)

The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

• PDF_2022-15-4-377-387 (Russian)

The Importance of Complementary Immunological Markers in the Diagnosis of Minimal Residual Disease in Multiple Myeloma

• PDF_2022-15-4-388-395 (Russian)

Cytogenetic Characterization of Complex Karyotypes by Multicolor FISH in Myelodysplastic Syndromes and Associated Acute Myeloid Leukemias

• PDF_2022-15-4-396-413 (Russian)

Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review

• PDF_2022-15-4-414-423 (Russian)